Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2–Activating Mutations: Results From the National Cancer Institute–Molecular Analysis for Therapy Choice ...
Since its development in the late 1970s, DNA sequencing has become one of the most influential tools in biomedical research, with technologies evolving continuously and new applications emerging over ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback